Boston, MA -- (SBWIRE) -- 09/09/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Brandywine Realty Trust (NYSE:BDN), EXCO Resources Inc (NYSE:XCO), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Fusion-IO, Inc.(NYSE:FIO)
Brandywine Realty Trust (NYSE:BDN) shares jumped 2.49% to $12.77. The company on Sept. 5 announced today that it has entered into an agreement with Parkway Properties, Inc. ("Parkway") to acquire two Trophy-class high rise assets located in Philadelphia's CBD, One and Two Commerce Square ("Commerce Square"), based on a $331.8 million valuation, or $175 per square foot. Closing of the acquisition is subject to customary closing conditions and the consummation of the merger between Parkway and Thomas Properties Group, Inc. ("Thomas").
Additionally, Stifel analyst John Guinee upgraded the rating on Brandywine Realty Trust on Sept. 6 from Hold to Buy, and named a $14.00 price target.
How Should Investors Trade BDN After The Recent Volatility? Get Free Report Here
EXCO Resources Inc (NYSE:XCO) shares gained 0.55% and closed at $7.33. The company on August 5 announced second quarter results for 2013. Adjusted net income was $0.10 per diluted share for the second quarter 2013 compared with $0.05 per diluted share for the second quarter 2012. GAAP results were net income of $86 million, or $0.40 per diluted share, for the second quarter 2013 compared with a net loss of $496 million, or $2.32 per diluted share, for the second quarter 2012.
How Should Investors Trade XCO After The Recent Volatility? Get Free Report Here
Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares climbed 1.70% to $8.98. The company, on Sept. 2, announced that the European Commission has granted Roche European Union (EU) marketing authorization for the use of a time-saving subcutaneous (SC) formulation of Herceptin(R) (trastuzumab) for the treatment of HER2-positive breast cancer. This formulation utilizes Halozyme's recombinant human hyaluronidase (rHuPH20) and is administered in two to five minutes, rather than 30 to 90 minutes with the standard intravenous form.
Is HALO A Good Buy After The Recent Price Movement? Find Out Here
Fusion-IO, Inc.(NYSE:FIO) shares gained 0.46% and closed at $10.83. The company on August 26 announced Fusion ioVDI software for virtual desktop infrastructure (VDI) acceleration. Based on the Fusion ioTurbine virtualization acceleration software and installed with Fusion ioMemory-based products in datacenter servers, ioVDI expands the Fusion-io software portfolio with a virtual desktop solution optimized for flash memory to deliver seamless, reliable, and cost-effective virtual desktop performance with consistent low latency response times for even data-intensive application workloads.
Is FIO A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaim
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)